Edition:
United States

Prothena Corp, Prothena Biosciences enter letter agreement with Boehringer Ingelheim


Wednesday, 12 Apr 2017 06:48am EDT 

Prothena Corporation Plc : Prothena Corporation - on April 5, 2017, co and Prothena Biosciences entered letter agreement with Boehringer Ingelheim Biopharmaceuticals GMBH . Prothena Corp - Boehringer Ingelheim reserved for Prothena capacity to manufacture and supply bulk drug substance of NEOD001, PRX003, possibly additional biologics .Prothena Corp - under agreement, Prothena made commitments for purchase of products from Boehringer Ingelheim. 

Company Quote

14.85
-0.2 -1.33%
20 Jul 2018